Related references
Note: Only part of the references are listed.HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review
Awoke Derbie et al.
INFECTIOUS AGENTS AND CANCER (2020)
The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
Shao-Kai Zhang et al.
FRONTIERS IN ONCOLOGY (2020)
Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression
Shuling Liu et al.
PLOS ONE (2018)
Comparative Evaluation of Three Commercial Systems for Detection of High-Risk Human Papillomavirus in Cervical and Vaginal ThinPrep PreservCyt Samples and Correlation with Biopsy Results
M. J. Binnicker et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Intracellular Human Papillomavirus E6, E7 mRNA Quantification Predicts CIN 2+in Cervical Biopsies Better Than Papanicolaou Screening for Women Regardless of Age
Deirdre Pierry et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia
Chih-Ming Ho et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The 2001 Bethesda System - Terminology for reporting results of cervical cytology
D Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
